Compound atlas
Healing

ARA-290

Also known as · Cibinetide

Peptide
Half-life
2h
approx. mean t½
Dose range
1–4 mg
typical, not prescriptive
Category
Healing
primary use-case
Single-dose decay
t½ = 2h · first-order model
~8h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m2h4h6h8h10h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

An 11-amino-acid EPO-derived peptide studied for neuropathic pain and tissue protection without EPO's blood effects.

Mechanism of action

Activates the innate repair receptor (EPOR/CD131) to reduce inflammation and promote tissue repair.

Typical protocol

1–4 mg subQ daily in cycles.

Storage

Reconstituted: refrigerated, ~30 days.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.